GTBP:GT Biopharma Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$8.61 NASDAQ 8:00a ET
August 14 '26 		GT Biopharma Reports Second Quarter 2026 Financial Results GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    GT Biopharma Reports Second Quarter 2026 Financial Results
     GlobeNewswire
    Full Story →

    Headline News
    A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
    11:20a ET July 6 '26 CNW Group
    A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
    11:20a ET July 6 '26 PR Newswire
    A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
    11:20a ET July 6 '26 PR Newswire
    More News →
    Day  39.3%Week  42.9%Month  15.8%More Charting →
    September 11 '26. Markets Closed.
    Last $8.61
    Day change   39.32%$2.43
    Open $6.59
    Gap at open $0.41
    Previous close $6.18
    Trading volume 544,275
    10 Day avg vol. 105,319
    Shares out. 1.8Mil
    Market cap. $15.5Mil
    Trading activity Above Avg.
    Previous data from yesterday, September 10 '26.

    Historical Price Performance
    3 month   22.95% 
    6 month   18.95% 
    1 year   57.22% 
    2 year   84.20% 

    Earnings
    Previous 12m -$35.41
    Next 12m Estimate -$10.75
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.